Akero Therapeutics Aktie
WKN DE: A2PLNP / ISIN: US00973Y1082
09.10.2025 22:48:03
|
Why Akero Therapeutics Stock Trounced the Market on Thursday
One of the best catalysts for sudden, sharp rise in the price of a stock is when the company behind it get acquired at a premium. Case in point: Akero Therapeutics (NASDAQ: AKRO), whose shares soared by more than 16% Thursday after it was revealed the biotech will have a new owner. That pop was especially impressive, given that the bellwether S&P 500 (SNPINDEX: ^GSPC) slumped by 0.3% on the day.Akero's buyer is none other than Novo Nordisk, the Denmark-based pharmaceutical company behind star weight loss drug Wegovy. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Akero Therapeutics Inc Registered Shs Accred Invmehr Nachrichten
Analysen zu Akero Therapeutics Inc Registered Shs Accred Invmehr Analysen
Aktien in diesem Artikel
Akero Therapeutics Inc Registered Shs Accred Inv | 46,57 | 17,22% |
|